Jacco Heldens

900 total citations
22 papers, 686 citations indexed

About

Jacco Heldens is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, Jacco Heldens has authored 22 papers receiving a total of 686 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 9 papers in Infectious Diseases and 8 papers in Immunology. Recurrent topics in Jacco Heldens's work include Influenza Virus Research Studies (15 papers), Respiratory viral infections research (11 papers) and Viral gastroenteritis research and epidemiology (5 papers). Jacco Heldens is often cited by papers focused on Influenza Virus Research Studies (15 papers), Respiratory viral infections research (11 papers) and Viral gastroenteritis research and epidemiology (5 papers). Jacco Heldens collaborates with scholars based in Netherlands, United States and Russia. Jacco Heldens's co-authors include Han van den Bosch, Harrie L. Glansbeek, Niels Hagenaars, Wim Jiskoot, Enrico Mastrobattista, J. T. M. Voeten, Larisa Rudenko, Irina Kiseleva, Rolf J. Verheul and B Martina and has published in prestigious journals such as Journal of Virology, Journal of Controlled Release and Journal of Clinical Microbiology.

In The Last Decade

Jacco Heldens

22 papers receiving 670 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jacco Heldens Netherlands	14	387	206	193	151	109	22	686
Masoumeh Tavassoti Kheiri Iran	14	214 0.6×	244 1.2×	133 0.7×	224 1.5×	87 0.8×	39	649
John B. Johnson United States	15	210 0.5×	266 1.3×	161 0.8×	156 1.0×	153 1.4×	31	731
Lisa Thomann Switzerland	13	88 0.2×	166 0.8×	153 0.8×	235 1.6×	30 0.3×	21	621
Maria Cândida M. Mellado Portugal	9	203 0.5×	169 0.8×	297 1.5×	310 2.1×	15 0.1×	10	783
Beatriz San Román Spain	15	104 0.3×	120 0.6×	68 0.4×	97 0.6×	60 0.6×	26	551
Byoung-Shik Shim South Korea	14	184 0.5×	139 0.7×	293 1.5×	158 1.0×	16 0.1×	23	614
Mohammed Yousuf Elahi Chowdhury Bangladesh	10	140 0.4×	142 0.7×	129 0.7×	110 0.7×	55 0.5×	20	406
Srinivas Garlapati United States	14	219 0.6×	198 1.0×	95 0.5×	175 1.2×	26 0.2×	25	586
Jibo Hou China	17	229 0.6×	94 0.5×	177 0.9×	192 1.3×	12 0.1×	57	651
Ian C Metcalfe Switzerland	9	173 0.4×	230 1.1×	190 1.0×	175 1.2×	38 0.3×	9	531

Countries citing papers authored by Jacco Heldens

Since Specialization

Citations

This map shows the geographic impact of Jacco Heldens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacco Heldens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacco Heldens more than expected).

Fields of papers citing papers by Jacco Heldens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacco Heldens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacco Heldens. The network helps show where Jacco Heldens may publish in the future.

Co-authorship network of co-authors of Jacco Heldens

This figure shows the co-authorship network connecting the top 25 collaborators of Jacco Heldens. A scholar is included among the top collaborators of Jacco Heldens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacco Heldens. Jacco Heldens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Heldens, Jacco, et al.. (2015). Antibodies enhance CXCL10 production during RSV infection of infant and adult immune cells. Cytokine. 76(2). 458–464. 10 indexed citations

Heldens, Jacco, Ellen G. J. Hulskotte, Paul E. Verweij, et al.. (2014). Safety and immunogenicity in man of a cell culture derived trivalent live attenuated seasonal influenza vaccine: A Phase I dose escalating study in healthy volunteers. Vaccine. 32(39). 5118–5124. 7 indexed citations

Heldens, Jacco, et al.. (2013). Fc gamma receptors in respiratory syncytial virus infections: implications for innate immunity. Reviews in Medical Virology. 24(1). 55–70. 9 indexed citations

Fang, Xu, et al.. (2012). An improved respiratory syncytial virus neutralization assay based on the detection of green fluorescent protein expression and automated plaque counting. Virology Journal. 9(1). 253–253. 38 indexed citations

Metz, Stefan, Corinne Geertsema, B Martina, et al.. (2011). Functional processing and secretion of Chikungunya virus E1 and E2 glycoproteins in insect cells. Virology Journal. 8(1). 353–353. 87 indexed citations

Isakova–Sivak, Irina, Li-Mei Chen, Yumiko Matsuoka, et al.. (2011). Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: A/Leningrad/134/17/57 (H2N2). Virology. 412(2). 297–305. 80 indexed citations

Kiseleva, Irina, J. T. M. Voeten, Natalie Larionova, et al.. (2011). Genome composition analysis of reassortant influenza viruses used in seasonal and pandemic live attenuated influenza vaccine. Molecular Genetics Microbiology and Virology. 26(4). 174–185. 12 indexed citations

Gustin, Kortney M., Taronna R. Maines, Jessica A. Belser, et al.. (2011). Comparative Immunogenicity and Cross-Clade Protective Efficacy of Mammalian Cell-Grown Inactivated and Live Attenuated H5N1 Reassortant Vaccines in Ferrets. The Journal of Infectious Diseases. 204(10). 1491–1499. 38 indexed citations

Verheul, Rolf J., Niels Hagenaars, Ethlinn V.B. van Gaal, et al.. (2011). A step-by-step approach to study the influence of N-acetylation on the adjuvanticity of N,N,N-trimethyl chitosan (TMC) in an intranasal nanoparticulate influenza virus vaccine. European Journal of Pharmaceutical Sciences. 45(4). 467–474. 11 indexed citations

10.

Glansbeek, Harrie L., et al.. (2011). Development and qualification of the parallel line model for the estimation of human influenza haemagglutinin content using the single radial immunodiffusion assay. Vaccine. 30(2). 201–209. 5 indexed citations

11.

Heldens, Jacco, et al.. (2010). Feasibility of single-shot H5N1 influenza vaccine in ferrets, macaques and rabbits. Vaccine. 28(51). 8125–8131. 13 indexed citations

12.

Voeten, J. T. M., Irina Kiseleva, Harrie L. Glansbeek, et al.. (2010). Master donor viruses A/Leningrad/134/17/57 (H2N2) and B/USSR/60/69 and derived reassortants used in live attenuated influenza vaccine (LAIV) do not display neurovirulent properties in a mouse model. Archives of Virology. 155(9). 1391–1399. 6 indexed citations

13.

Hagenaars, Niels, Ivo Que, Bram Slütter, et al.. (2010). Role of trimethylated chitosan (TMC) in nasal residence time, local distribution and toxicity of an intranasal influenza vaccine. Journal of Controlled Release. 144(1). 17–24. 54 indexed citations

14.

Bodewes, Rogier, Joost H. C. M. Kreijtz, Geert van Amerongen, et al.. (2010). A Single Immunization with CoVaccine HT-Adjuvanted H5N1 Influenza Virus Vaccine Induces Protective Cellular and Humoral Immune Responses in Ferrets. Journal of Virology. 84(16). 7943–7952. 32 indexed citations

15.

Hagenaars, Niels, Enrico Mastrobattista, Rolf J. Verheul, et al.. (2009). Physicochemical and Immunological Characterization of N,N,N-Trimethyl Chitosan-Coated Whole Inactivated Influenza Virus Vaccine for Intranasal Administration. Pharmaceutical Research. 26(6). 1353–1364. 47 indexed citations

16.

Bodewes, Rogier, Martina M. Geelhoed-Mieras, Jacco Heldens, et al.. (2009). The novel adjuvant CoVaccineHT™ increases the immunogenicity of cell-culture derived influenza A/H5N1 vaccine and induces the maturation of murine and human dendritic cells in vitro. Vaccine. 27(49). 6833–6839. 18 indexed citations

17.

Hagenaars, Niels, Rolf J. Verheul, Enrico Mastrobattista, et al.. (2009). Relationship between structure and adjuvanticity of N,N,N-trimethyl chitosan (TMC) structural variants in a nasal influenza vaccine. Journal of Controlled Release. 140(2). 126–133. 49 indexed citations

18.

Kiseleva, Irina, J. T. M. Voeten, Natalie Larionova, et al.. (2009). PB2 and PA genes control the expression of the temperature-sensitive phenotype of cold-adapted B/USSR/60/69 influenza master donor virus. Journal of General Virology. 91(4). 931–937. 32 indexed citations

19.

Hagenaars, Niels, Enrico Mastrobattista, Harrie L. Glansbeek, et al.. (2008). Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: Effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model. Vaccine. 26(51). 6555–6563. 65 indexed citations

20.

Heldens, Jacco, et al.. (1995). Cloning and characterization of the bgxA gene from Erwinia chrysanthemi D1 which encodes a β-glucosidase/xylosidase enzyme. Molecular and General Genetics MGG. 246(4). 465–477. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact